Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.44 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.44 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.39 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 3/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27703606 | 1.00 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL9393373 | 0.92 | SLC28A1 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Triphosphate SCHEMBL27589399 | 0.89 | P2RY6 (0.52) | P2RY6P2RY2P2RY4 | |
| Uridine SCHEMBL27699068 | 0.88 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL28786348 | 0.84 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL51723 | 0.84 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL986335 | 0.83 | P2RY6 (0.50) | P2RY6DUTP2RY2P2RY4 | |
| SCHEMBL414705 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2242410 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| Hydrochloric Acid SCHEMBL27782735 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17584 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101943-A1 | ANTI-HUMAN CLAUDIN-18.2 ANTIBODIES FOR IN VITRO DIAGNOSTICS | AGILENT TECHNOLOGIES, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-12612662-B2 | DNA repair site detection for personal genomics, epigenomics, and gene therapy | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-04-28 | — | — | US | claimed |
| US-12570704-B2 | Functionally modified maytansinoids and compositions and methods of use thereof | University of Georgie Research Foundation, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-20260049142-A1 | ANTI-HUMAN ICOS ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND FOR DIAGNOSING CANCER | AGILENT TECHNOLOGIES, INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4687863-A1 | RADIOPROTECTION BY INHIBITION OF SUPEROXIDE DISMUTASE 1 | Deutsches Krebsforschungszentrum (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4677107-A1 | METHOD FOR NATIVE STRAND SEQUENCING OF ENRICHED GENOMIC REGIONS | Nanohyb, LLC (US) | 2026-01-14 | — | — | EP | claimed |
| US-12473663-B2 | Compositions and methods for immune repertoiresequencing | Life Technologies Corporation (US) | 2025-11-18 | — | — | US | claimed |
| EP-4623073-A2 | METHODS FOR ASSESSING PROLIFERATION POTENCY OF GENE-EDITED T CELLS | Iovance Biotherapeutics, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| EP-4069255-B1 | IDENTIFYING NON-PRODUCTIVE SPLICE SITES | UNIV MASSACHUSETTS (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250257104-A1 | TARGETED INTRACELLULAR DELIVERY OF LARGE NUCLEIC ACIDS | HOFFMANN-LA ROCHE INC. (US) | 2025-08-14 | — | — | US | claimed |
| WO-1991006674-A1 | METHOD AND DEVICE FOR THE DETECTION OF ANTIBIOTIC RESISTANCE | SCOTGEN LTD. (GB) | 1991-05-16 | — | — | WO | claimed |
| EP-0397753-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES. | ADVANCED RIVERINA HOLDINGS (AU) | 1990-11-22 | — | — | EP | claimed |
| EP-0276287-A4 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1989-09-19 | — | — | EP | claimed |
| EP-0119025-B1 | THYMIDINE KINASE-NEGATIVE TEMPERATURE RESISTANT BOVINE HERPESVIRUS-1 MUTANT AS A VACCINE AGAINST INFECTIOUS BOVINE RHINOTRACHEITIS | Baylor College of Medicine (US) | 1989-09-13 | — | — | EP | claimed |
| WO-1989007154-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | ADVANCED RIVERINA HOLDINGS LIMITED (AU) | 1989-08-10 | — | — | WO | claimed |
| US-4780406-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-10-25 | — | — | US | claimed |
| EP-0276287-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1988-08-03 | — | — | EP | claimed |
| WO-1988001300-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1988-02-25 | — | — | WO | claimed |
| US-4585736-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-04-29 | — | — | US | claimed |
| EP-0114670-A2 | Novel cell lines for use in the preparation of hybridoma cells | SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) | 1984-08-01 | — | — | EP | claimed |